Atricure Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
1,350
- Stock Symbol
-
ATRC
- Investments
-
5
- Share Price
-
$54.03
- (As of Thursday Closing)
Atricure General Information
Description
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Contact Information
Website
www.atricure.comCorporate Office
- 7555 Innovation Way
- Mason, OH 45040
- United States
Corporate Office
- 7555 Innovation Way
- Mason, OH 45040
- United States
Atricure Stock Performance
As of 19-Nov-2026, Atricure’s stock price is $54.03. Its current market cap is $2.76B with 50.9M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $54.03 | $55.45 | $25.36 - $66.02 | $2.76B | 50.9M | 1.04M | $0.31 |
Atricure Financials Summary
As of 30-Sep-2026, Atricure has a trailing 12-month revenue of $590M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 2,761,948 | 1,895,669 | 1,436,692 | 1,632,891 |
| Revenue | 589,803 | 534,528 | 465,307 | 399,245 |
| EBITDA | 37,979 | 11,767 | (22,968) | (11,901) |
| Net Income | 14,883 | (11,448) | (44,698) | (30,438) |
| Total Assets | 717,536 | 654,179 | 609,328 | 613,932 |
| Total Debt | 93,105 | 73,381 | 73,725 | 74,494 |
Atricure Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Atricure Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Atricure Comparisons
Industry
Financing
Details
Atricure Competitors (47)
One of Atricure’s 47 competitors is Merit Medical Systems, a Corporation company based in South Jordan, UT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Merit Medical Systems | Corporation | South Jordan, UT | ||||
| Artivion | Formerly PE-Backed | Kennesaw, GA | ||||
| Cordis | Private Equity-Backed | Miami Lakes, FL | ||||
| Elliquence | Corporate Backed or Acquired | Baldwin, NY | ||||
| Sisram Medical | Formerly PE-Backed | Caesarea, Israel |
Atricure Patents
Atricure Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260345172-A1 | Bypass graft friendly exclusion clip | Pending | 30-Apr-2025 | ||
| WO-2026231802-A1 | Occlusion clip, deployer, and related methods | Pending | 30-Apr-2025 | ||
| US-20260341182-A1 | Knee amputation training model and methods of use | Pending | 29-Apr-2025 | ||
| US-20260256510-A1 | Methods and devices for ablation of tissue | Pending | 28-Feb-2025 | ||
| WO-2026182789-A1 | Methods and devices for ablation of tissue | Pending | 28-Feb-2025 | A61B18/1445 |
Atricure Signals
Atricure Investments & Acquisitions (5)
Atricure’s most recent deal was a Merger/Acquisition with SentreHEART for . The deal was made on 13-Aug-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SentreHEART | 13-Aug-2019 | Merger/Acquisition | Surgical Devices | ||
| nContact | 13-Oct-2015 | Merger/Acquisition | Surgical Devices | ||
| Estech | 31-Dec-2013 | Merger/Acquisition | Medical Supplies | ||
| CooperSurgical (Frigitronics cryogenic product) | 07-Aug-2007 | Corporate Asset Purchase | Buildings and Property | ||
| Enable Medical | 10-Aug-2005 | Merger/Acquisition | Surgical Devices |
Atricure ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
27.01 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Atricure FAQs
-
When was Atricure founded?
Atricure was founded in 2000.
-
Where is Atricure headquartered?
Atricure is headquartered in Mason, OH.
-
What is the size of Atricure?
Atricure has 1,350 total employees.
-
What industry is Atricure in?
Atricure’s primary industry is Surgical Devices.
-
Is Atricure a private or public company?
Atricure is a Public company.
-
What is Atricure’s stock symbol?
The ticker symbol for Atricure is ATRC.
-
What is the current stock price of Atricure?
As of 19-Nov-2026 the stock price of Atricure is $54.03.
-
What is the current market cap of Atricure?
The current market capitalization of Atricure is $2.76B.
-
What is Atricure’s current revenue?
The trailing twelve month revenue for Atricure is $590M.
-
Who are Atricure’s competitors?
Merit Medical Systems, Artivion, Cordis, Elliquence, and Sisram Medical are some of the 47 competitors of Atricure.
-
What is Atricure’s annual earnings per share (EPS)?
Atricure’s EPS for 12 months was $0.31.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process